Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder

International Journal of Neuropsychopharmacology

Volumn 6, Issue 4, 2003, Pages 421-424

  Washizuka, Shinsuke ^a   Ikeda, Akifumi ^b   Kato, Nobumasa ^c   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bipolar disorder; Lithium response; Mitochondrial DNA; Pharmacogenetics; Treatment

Indexed keywords

LITHIUM; MITOCHONDRIAL DNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; CALCIUM CELL LEVEL; CHROMOSOMAL LOCALIZATION; DNA POLYMORPHISM; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RELAPSE;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DNA, MITOCHONDRIAL; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; JAPAN; LITHIUM CARBONATE; LONG-TERM CARE; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, GENETIC; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 0742270812     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003778     Document Type: Article

References (27)

1. 2+ signaling. Current Opinion in Neurobiology 8, 398-404.
2. Del Zompo M, Ardau R, Palmas MA, Bocchetta A, Reina A, Piccardi MP (1999). Lithium response: association study with two candidate genes. Molecular Psychiatry 4, S66-S67.
3. Engstrom C, Astrom M, Nordqvist-Karlsson B, Adolfsson R, Nylander PO (1997). Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Biological Psychiatry 42, 425-433.
4. Goodwin FK, Jamison KR (1990). Manic-depressive Spectrum. New York: Oxford University Press.
5. Ikeda A, Kato N (2003). Biological predictors of lithium response. Psychiatry and Clinical Neurosciences 57, 243-250.
6. Kato T, Fujii K, Kamiya A, Kato N (2000c). White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder: a preliminary observation. Psychiatry and Clinical Neurosciences 54, 117-120.
7. 31P-MRS in bipolar disorder. International Journal of Neuropsychopharmacology 3, 83-85.
8. Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disorder 2, 180-190.
9. Kato T, Kunugi H, Nanko S, Kato N (2000b). Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. American Journal of Medical Genetics 96, 182-186.
10. Kato T, Kunugi H, Nanko S, Kato N (2001). Mitochondrial DNA polymorphisms in bipolar disorder. Journal of Affective Disorders 62, 151-164.
11. 7Li magnetic resonance spectroscopy. Journal of Affective Disorders 27, 53-59.
12. Lovlie R, Berle JO, Stordal E, Steen VM (2001). The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism. Psychiatric Genetics 11, 41-43.
13. MacQueen GM, Young LT, Robb JC, Marriott M, Cooke RG, Joffe RT (2000). Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatrica Scandinavica 101, 374-381.
14. Maj M, Pirozzi R, Starace F (1989). Previous pattern of illness as a predictor of response to lithium prophylaxis in bipolar patients. Journal of Affective Disorders 17, 237-241.
15. McMahon FJ, Chen YS, Patel S, Kokoszka J, Brown MD, Torroni A, DePaulo JR, Wallace DC (2000). Mitochondrial DNA sequence diversity in bipolar affective disorder. American Journal of Psychiatry 157, 1058-1064.
16. Schurhoff F, Bellivier F, Jouvent R, Mouren-Simeoni MC, Bouvard M, Allilaire JF, Leboyer M (2000). Early and late onset bipolar disorders: two different forms of manic-depressive illness? Journal of Affective Disorders 58, 215-221.
17. Serretti A (2002). Lithium long-term treatment in mood disorders: clinical and genetic predictors. Pharmacogenomics 3, 117-129.
18. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E (1999). Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. Journal of Psychiatric Research 33, 371-377.
19. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E (2001). Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics Journal 1, 71-77.
20. Sherer TB, Trimmer PA, Borland K, Parks JK, Bennett Jr. JP, Tuttle JB (2001). Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Research 891, 94-105.
21. Steen VM, Lovlie R, Osher Y, Belmaker RH, Berle JO, Gulbrandsen AK (1998). The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 8, 259-268.
22. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K (1998). Mitochondrial genotype associated with longevity. Lancet 351, 185-186.
23. Taylor R, Mallinger AG, Frank E, Rucci P, Thase ME, Kupfer DJ (2001). Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome. Neuropsychopharmacology 24, 192-197.
24. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, Berghofer A, Muller-Oerlinghausen B, Dvorakova M, Libigerova E, Vojtechovsky M, Zvolsky P, Joober R, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Rouleau GA, Alda M (1998). Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder. Molecular Psychiatry 3, 534-538.
25. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C, Cavazzoni P, Duffy A, Betard C, Zvolsky P, Robertson C, Brewer C, Hudson TJ, Rouleau GA, Alda M (2001). Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Molecular Psychiatry 6, 570-578.
26. Viguera AC, Baldessarini RJ, Tondo L (2001). Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disorder 3, 245-252.
27. Watanabe S, Ebara T (1983). Lithium Treatment of Manic-depressive Illness [in Japanese]. Tokyo, Japan: Igaku-Shoin Ltd.